Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin.

Saved in:
Bibliographic Details
Title: Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin.
Authors: Outla Z; Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Kosla J; Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Prechova M; Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Frick L; Institute of Neuropathology, University Hospital Zurich, University of Zurich, Switzerland., Bortel P; Department of Analytical Chemistry, University of Vienna, Austria., Borutzki Y; Institute of Inorganic Chemistry, University of Vienna, Austria., Bileck A; Department of Analytical Chemistry, University of Vienna, Austria.; Joint Metabolome Facility, Medical University of Vienna and University of Vienna, Austria., Gerner C; Department of Analytical Chemistry, University of Vienna, Austria.; Joint Metabolome Facility, Medical University of Vienna and University of Vienna, Austria., Meier-Menches SM; Department of Analytical Chemistry, University of Vienna, Austria.; Institute of Inorganic Chemistry, University of Vienna, Austria.; Joint Metabolome Facility, Medical University of Vienna and University of Vienna, Austria., Osmanagic-Myers S; Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.; Center for Pathobiochemistry and Genetics, Medical University of Vienna, Austria., Gregor M; Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
Source: Molecular oncology [Mol Oncol] 2026 Jun; Vol. 20 (6), pp. 1453-1472. Date of Electronic Publication: 2025 Dec 30.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1878-0261
DOI:10.1002/1878-0261.70186